Blog
Softening of public attitude towards COVID-19 vaccines
In December Talking Medicines carried out two ‘pulse’ surveys of the UK public to gauge opinion towards COVID-19 vaccines and found that over the month, attitude had softened, with more people intending to take the vaccine once it becomes available to them. The...
Growing the Product Tech Team
We are so pleased to welcome four talented individuals to our team. Through their knowledge and experience, we look forward to accelerating our AI driven data insights product aligned to the needs of our commercial marketing pharmaceutical customers. Stewart McKee -...
Arthritis drugs could save the lives of critically ill COVID-19 patients
Using existing drugs in different, unintended therapy areas is no new proposition. Exploring other uses of medicines can result in the bypass of significant obstacles that exist in the traditional roadmap of a drug’s development. Reduced research time and lesser...
AstraZeneca and Oxford University gain approval on new COVID-19 vaccine
The UK has now approved its second vaccine for COVID-19. Last week, AstraZeneca (Pharmaceutical company) and Oxford University’s vaccine was approved for use and has since been administered to the public. From this week there will be half a million doses available for...
Is the pharma industry ready to listen directly to patients?
COO Elizabeth Fairley was recently interviewed by publisher Drug Discovery World on whether the pharmaceutical industry is ready to listen directly to patients? Elizabeth commented that "There has been a growing realisation that pharmaceutical companies must change if...
Pfizer and BioNTech gain approval on new COVID-19 vaccine
This long-awaited moment has finally arrived! This morning, Pfizer and BioNTech’s vaccine has been approved for use in the UK as early as next week. It is the fastest vaccine ever to be developed, taking only 10 months to convert the concept into reality, a process...
Protecting Your Medical Data with Elizabeth Fairley and Ellie Halliday
DIGIT spoke with Elizabeth Fairley and Ellie Halliday of Talking Medicines about keeping your medical data safe in a Covid world. Medical data is among the most sensitive information a company can gather, store or track, and the coronavirus pandemic has heightened...
COVID-19 Vaccine: A fresh start
There is no doubt that 2020 has been a long, hard year. With the endless threat of new measures and long lockdowns, it is safe to say we could do with some good news. Finally, we have a glimmer of hope. First, Pfizer (Pharmaceutical company) announced the interim...
Talking Medicines identified as top AI Company
Data tech innovator Talking Medicines, which uses advanced AI to provide pharmaceutical companies with real-time data intelligence, has been chosen to join Tech Nation’s Applied AI 2.0 Growth Programme. Tech Nation’s growth programmes are designed to champion and...